Release Date: 18/02/22 08:38 Summary: FIRB Condition Satisfied for Proposed Scheme Price Sensitive: Yes Download Document 277.95KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling